Results 81 to 90 of about 1,397,954 (306)

Parathyroid carcinoma in tertiary hyperparathyroidism

open access: yesAsian Journal of Surgery, 2016
Parathyroid carcinoma is a rare disease of unknown etiology. This study presents a case of parathyroid carcinoma in a patient with tertiary hyperparathyroidism.
Byung Seup Kim   +3 more
doaj   +1 more source

Concomitant Hyperparathyroidism Due to Occult Parathyroid Adenoma Detected by Technetium-99m Sestamibi Single-photon Computed Tomography/Computerized Tomography in a Patient with Papillary Thyroid Carcinoma

open access: yesJournal of Health Science and Medical Research (JHSMR), 2020
Although the occurrence of thyroid and parathyroid diseases is common, concomitant parathyroid adenoma and papillary thyroid carcinoma is rare. We report the case of a 77-year-old Thai woman who was diagnosed to have papillary thyroid carcinoma and ...
Jiraporn Sriprapaporn   +2 more
doaj   +1 more source

Multimodal Deep Learning for Personalized Renal Cell Carcinoma Prognosis: Integrating CT Imaging and Clinical Data [PDF]

open access: yesarXiv, 2023
Renal cell carcinoma represents a significant global health challenge with a low survival rate. This research aimed to devise a comprehensive deep-learning model capable of predicting survival probabilities in patients with renal cell carcinoma by integrating CT imaging and clinical data and addressing the limitations observed in prior studies. The aim
arxiv  

Detecting Invasive Ductal Carcinoma with Semi-Supervised Conditional GANs [PDF]

open access: yesProceedings of the Future Technologies Conference (FTC) 2020, vol. 3, pp.113-120, 2019
Invasive ductal carcinoma (IDC) comprises nearly 80% of all breast cancers. The detection of IDC is a necessary preprocessing step in determining the aggressiveness of the cancer, determining treatment protocols, and predicting patient outcomes, and is usually performed manually by an expert pathologist.
arxiv   +1 more source

Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.

open access: yesThe Oncologist, 2018
BACKGROUND Parathyroid carcinoma (PC) is a rare endocrine malignancy that can cause life-threatening hypercalcemia. We queried whether comprehensive genomic profiling (CGP) of PC might identify genomic alterations (GAs), which would suggest benefit from ...
Hyunseok Kang   +12 more
semanticscholar   +1 more source

Prognosis and Phenotypes of Advanced Head and Neck Carcinoma Associated With Hypercalcemia

open access: yesHead &Neck, EarlyView.
ABSTRACT Purpose Hypercalcemia is the most common metabolic disorder in cancer, affecting 10%–20% of patients with advanced malignancies, including squamous cell carcinoma of the head and neck (HNSCC), though its prognostic significance remains poorly studied.
Elodie Mamou   +5 more
wiley   +1 more source

Prevalence of function‐limiting late effects in survivors of head and neck cancer

open access: yesPM&R, EarlyView.
Abstract Background Survivors of head and neck cancer (HNC) are commonly affected by multiple complex and interrelated long‐term and late effects that can adversely affect their function and quality of life. Objective To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality ...
Yu Hui Won, Michael D. Stubblefield
wiley   +1 more source

Late recurrence of a single gland primary hyperparathyroidism—Atypical parathyroid adenoma or misdiagnosed parathyroid carcinoma

open access: yesClinical Case Reports
Key Clinical Message This case report aims to raise awareness of differential diagnoses of hypercalcemia and primary hyperparathyroidism, including parathyroid carcinoma and atypical adenoma, and to highlight the diagnostic challenges.
Jessica Kotliarevskaia   +3 more
doaj   +1 more source

Metastatic parathyroid carcinoma: A tale of refractory hypercalcemia

open access: yesJournal of Clinical and Translational Endocrinology Case Reports, 2023
Background/objective: Parathyroid carcinoma is a rare entity presenting as parathyroid hormone (PTH) dependent hypercalcemia. Our objective was to report a case of metastatic parathyroid carcinoma in a middle-aged woman, who presented with refractory ...
Johns T. Johnson   +7 more
doaj  

The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report

open access: yesBMC Nephrology, 2017
Background Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving chronic dialysis therapy. Although cinacalcet can control parathyroid function and bone turnover, preventing ectopic calcification remains challenging ...
Daisuke Takada   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy